↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

360 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 10-mg dose of e5501 cyclodextrin oral solution - - - - 1件: 63 💬
2 10-mg dose of e5501 lipid-based oral - - - - 1件: 63 💬
3 2% chlorhexidine solution wipes Chlorhexidine 4件: D00858, D01345, D03463, D07668 💬 - - 1件: 299 💬
4 20 mg sildenafil citrate by mouth Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
5 4% chlorhexidine gluconate liquid skin cleanser Chlorhexidine 4件: D00858, D01345, D03463, D07668 💬 - - 1件: 299 💬
6 5% sildenafil cream Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 50 💬
7 750 mg metformin and 7.5 g l-citrulline daily p.o. Citrulline 3件: D00944, D04966, D07706 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 113 💬
8 [14c]-rpc1063 solution (0.1 mg/ml) for oral administration - - - - 3件: 13, 96, 97 💬
9 A novel synthetic, orally-administered, non-peptide small molecule, which acts as - - - - 1件: 254 💬
10 Access program - sildenafil citrate, viagra, revatio Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
11 Acetohydroxamic acid oral tablet [lithostat] Acetohydroxamic acid 1件: D00220 💬 - - 1件: 251 💬
12 Adempas - 0,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 1件: 86 💬
13 Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
14 Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
15 Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
16 Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse - - - - 2件: 51, 86 💬
17 All subjects will receive maraviroc 300mg orally twice a day for 6 weeks Maraviroc 1件: D06670 💬 1件: CCR5 💬 9件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 1件: 84 💬
18 Alvelestat oral tablet - dose 1 Alvelestat - - - 1件: 231 💬
19 Alvelestat oral tablet - dose 2 Alvelestat - - - 1件: 231 💬
20 Amifampridine phosphate 10 mg oral tablet Amifampridine 1件: D10228 💬 4件: KCNA4, KCNC3, KCND2, KCND3 💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 1件:  3  💬
21 Amt-101 (oral) - - - - 1件: 97 💬
22 Anavex2-73 oral liquid - - - - 1件: 156 💬
23 Antihistamine (cetirizine or equivalent) Cetirizine 2件: D00664, D07662 💬 1件: HRH1 💬 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 1件: 35 💬
24 Aspirin 650mg oral capsule Acetylsalicylic acid 1件: D00109 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 13 💬
25 Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse - - - - 1件: 13 💬
26 Azd4017 and prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 75 💬
27 Azp2006 oral solution - - - - 1件:  5  💬
28 Bardoxolone methyl oral capsule Bardoxolone 2件: D09584, D09585 💬 - - 1件: 67 💬
29 Bladder instillation with triamcinolone acetonide Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 226 💬
30 Bladder instillation without triamcinolone acetonide Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 226 💬
31 Bosentan and sildenafil Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
32 Budesonide oral suspension Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
33 Budesonide oral suspension [0.2 mg/ml] Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
34 Cannabidiol oral solution Cannabidiol 1件: D10915 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 4件: 140, 144, 145, 193 💬
35 Carbidopa 200mg oral dose Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 2件:  6 , 17 💬
36 Carbidopa-levodopa 25 mg-100 mg oral tablet Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
37 Cbd - oral solution, is known as epidiolex, and is the approved name in the usa. - - - - 3件: 140, 144, 158 💬
38 Cbd - oral solution, is known as epidyolex, and is the approved name - - - - 1件: 156 💬
39 Cbd oral solution, is known as epidyolex and is the approved name in the eu - - - - 1件: 156 💬
40 Cbd-oral solution, is known as epidiolex, and is the approved name in the usa. - - - - 1件: 158 💬
41 Cephalexin Cephalexin 2件: D00263, D00906 💬 - - 1件: 299 💬
42 Cetirizine Cetirizine 2件: D00664, D07662 💬 1件: HRH1 💬 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 2件: 13, 35 💬
43 Cetirizine hydrochloride Cetirizine 2件: D00664, D07662 💬 1件: HRH1 💬 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 1件: 13 💬
44 Chlorhexidine Chlorhexidine 4件: D00858, D01345, D03463, D07668 💬 - - 2件: 86, 299 💬
45 Chlorhexidine gluconate Chlorhexidine 4件: D00858, D01345, D03463, D07668 💬 - - 1件: 299 💬
46 Chlorhexidine gluconate oral rinse Chlorhexidine 4件: D00858, D01345, D03463, D07668 💬 - - 1件: 299 💬
47 Cialis - 20 mg 2 compresse rivestite con film in blister uso orale - - - - 1件: 75 💬
48 Cladribina oral Cladribine 1件: D01370 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 13 💬
49 Cladribine oral tablet Cladribine 1件: D01370 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 13 💬
50 Cohort 1:nilotinib oral capsules (150mg or 300mg) Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
51 Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1) Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
52 Colchicine 1 mg oral tablet Colchicine 1件: D00570 💬 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 1件:  2  💬
53 Combination oral budesonide and rectal hydrocortisone Budesonide 2件: D00088, D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
54 Combination therapy with vigabatrin and prednisolone Prednisolone 9件: D00472, D00535, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 2件: ABAT, NR3C1 💬 8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件: 145 💬
55 Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) Acetate 21件: D00088, D00292, D00472, D00473, D00973, D00975, D00980, D00981, D00982, D01239, D01510, D01615, D01632, D01948, D01998, D02156, D02174, D02591, D02592, D03301, D07749 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
56 Corticosteroid (prednisolone) Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 85 💬
57 Corticosteroid treatment (methylprednisolone or prednisolone) Methylprednisolone 14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 64 💬
58 Corticosteroids (prednisone or prednisolone) Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 49 💬
59 Cosyntropin injectable suspension 1 mg/ml + vigabatrin Tetracosactide 2件: D00284, D00535 💬 2件: ABAT, MC2R 💬 12件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 1件: 145 💬
60 Cultivated oral mucosal epithelial sheet transplantation - - - - 2件: 38, 162 💬
61 Cx-4945 oral formulation - - - - 1件: 331 💬
62 Cyclophosphamide 50mg oral tablet Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 162 💬
63 Cyclosporine oral product Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 60 💬
64 Deferasirox Deferasirox 1件: D03669 💬 - - 3件: 254, 284, 286 💬
65 Deferiprone 80 mg/ml oral solution Deferiprone 1件: D07416 💬 - - 1件: 120 💬
66 Deferiprone 80 mg/ml oral solution (ferriprox) Deferiprone 1件: D07416 💬 - - 1件: 120 💬
67 Deferiprone oral solution Deferiprone 1件: D07416 💬 - - 1件: 120 💬
68 Desmopressin oral melt Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 1件: 72 💬
69 Deutetrabenazine oral tablet [austedo] Deutetrabenazine 1件: D10701 💬 1件: SLC18A2 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 1件:  8  💬
70 Device: frequently sampled oral glucose tolerance test and cgm Dextrose, unspecified form - - - 1件: 299 💬
71 Device: home oral glucose tolerance test kit Dextrose, unspecified form - - - 1件: 299 💬
72 Device: iowa oral performance instrument - - - - 1件:  2  💬
73 Device: iowa oral pressure instrument - - - - 1件:  2  💬
74 Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland). Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 235 💬
75 Diagnostic test: oral glucose tolerance test Dextrose, unspecified form - - - 3件: 13, 65, 299 💬
76 Dronabinol 25 mg/ml, oral drops Dronabinol 1件: D00306 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 1件: 13 💬
77 Duo-therapy with sildenafil + bosentan Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
78 E5501 40 mg 2 x 20-mg tablets, orally, fasted - - - - 1件: 63 💬
79 E5501 40 mg 2 x 20-mg tablets, orally, with food - - - - 1件: 63 💬
80 E5501 40mg 2 x 20-mg tablets, orally, fasted - - - - 1件: 63 💬
81 Eltrombopag oral tablets Eltrombopag 1件: D03978 💬 - - 1件: 63 💬
82 Entacapone 400mg oral dose Entacapone 1件: D00781 💬 1件: COMT 💬 4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 2件:  6 , 17 💬
83 Enterabio's oral parathyroid hormone (1-34) Parathyroid hormone 1件: D05364 💬 2件: PTH1R, PTH2R 💬 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 1件: 235 💬
84 Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) Bosentan 6件: D01227, D02008, D02229, D07538, D08514, D10135 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
85 Erythrocine oral - - - - 1件: 36 💬
86 Etanercept, methotrexate, prednisolone Etanercept 11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬 5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 56 💬
87 Everolimus oral product Everolimus 1件: D02714 💬 1件: MTOR 💬 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 2件: 89, 158 💬
88 Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14) - - - - 1件: 13 💬
89 Fentanyl Fentanyl 2件: D00320, D01399 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 4件: 46, 70, 215, 231 💬
90 Fentanyl (high dose) Fentanyl 2件: D00320, D01399 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 215 💬
91 Fentanyl (low dose) Fentanyl 2件: D00320, D01399 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 215 💬
92 Fentanyl (low dose) + dexmedetomidine Dexmedetomidine 4件: D00320, D00514, D01205, D01399 💬 4件: ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件: 215 💬
93 Fentanyl transdermal patch Fentanyl 2件: D00320, D01399 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 46 💬
94 Ferrous sulphate 200mg oral tablet - - - - 1件: 227 💬
95 Fipamezole hydrochloride 30 mg oral disintegrating tablets Fipamezole - - - 2件:  6 , 17 💬
96 Fipamezole hydrochloride 60 mg oral disintegrating tablets Fipamezole - - - 2件:  6 , 17 💬
97 Fipamezole hydrochloride 90 mg oral disintegrating tablets Fipamezole - - - 2件:  6 , 17 💬
98 Firdapse - 10 mg - compresse - uso orale - blister(alu/pvc/pvdc) 100 x 1 compresse - - - - 1件: 11 💬
99 Flucloxacillin 250mg/5ml sugar-free powder for oral solution Flucloxacillin 3件: D01249, D04196, D07965 💬 - - 1件: 299 💬
100 Flx-787-odt (orally disintegrating tablet) - - - - 1件: 10 💬
101 Flx-787-odt (orally disintigrating tablet) - - - - 1件:  2  💬
102 Fmt oral - - - - 1件: 97 💬
103 G04be03- sildenafil - sildenafil (citrato) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
104 Glatiramer acetate injection with oral cetirizine hydrochloride Acetate 3件: D00664, D04318, D07662 💬 21件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, HRH1 💬 35件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
105 Glpg0259 oral capsule - - - - 1件: 46 💬
106 Glucocorticoid (prednisone or prednisolone) Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
107 Glucophage (metformin) Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 2件: 46, 75 💬
108 Ibuprofen Ibuprofen 4件: D00126, D01122, D04490, D06606 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 6件: 13, 46, 65, 113, 271, 299 💬
109 Ibuprofen 200mg Ibuprofen 4件: D00126, D01122, D04490, D06606 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 113 💬
110 Ibuprofen sandoz 400 mg filmtabletten Ibuprofen 4件: D00126, D01122, D04490, D06606 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 13 💬
111 Idl-2965 oral capsule - - - - 1件: 85 💬
112 Ins1007 10 mg oral tablet - - - - 1件: 299 💬
113 Ins1007 25 mg oral tablet - - - - 1件: 299 💬
114 Interferon alpha oral lozenge - - - - 1件: 85 💬
115 Interferon beta 1a, oral doxycycline Doxycycline 6件: D00307, D02129, D03903, D03904, D04554, D07876 💬 2件: IFNAR1, IFNAR2 💬 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 1件: 13 💬
116 Intra plexus triamcinolone and bupivicaine injection Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 298 💬
117 Intravenous and oral n-acetyl cysteine Cysteine 2件: D00026, D02326 💬 - - 1件:  6  💬
118 Intravenous methyl prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 43 💬
119 Iohexol Iohexol 1件: D01817 💬 - - 2件: 19, 67 💬
120 Iohexol inj 300 milligrams per milliliter (mg/ml) Iohexol 1件: D01817 💬 - - 1件: 67 💬
121 Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) - - - - 1件: 67 💬
122 Jinarc - 15 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse - - - - 1件: 67 💬
123 Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) - - - - 1件: 67 💬
124 Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) - - - - 1件: 67 💬
125 Jinarc - 30 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse - - - - 1件: 67 💬
126 L-citrulline and metformin & l-citrulline Citrulline 3件: D00944, D04966, D07706 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 113 💬
127 Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
128 Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
129 Liprotamase powder for oral solution - - - - 1件: 299 💬
130 Lo-ovral oral contraceptive pills - - - - 1件: 60 💬
131 Lodotra (delayed release prednisolone) Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 41 💬
132 Long-circulating liposomal prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
133 Low dose prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
134 Maximal oral 5asa - - - - 1件: 97 💬
135 Medium dose prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
136 Megadose oral methylprednisolone Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
137 Meloxicam oral suspension Meloxicam 1件: D00969 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 46 💬
138 Memantine hydrochloride oral solution Memantine 2件: D04905, D08174 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  2  💬
139 Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet Mesalazine 2件: D00377, D02486 💬 - - 1件: 97 💬
140 Metformin Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
141 Metformin (generic) Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 158 💬
142 Metformin 500mg Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 113 💬
143 Metformin and metformin & l-citrulline Citrulline 3件: D00944, D04966, D07706 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 113 💬
144 Metformin hcl Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 285 💬
145 Metformin hydrochloride Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 5件: 81, 158, 265, 299, 301 💬
146 Metformin treatment Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 46 💬
147 Metformin/cp-690,550 Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 46 💬
148 Methotrexate - etanercept - prednisolone arm Etanercept 11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬 5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
149 Methyl prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 43, 49, 96 💬
150 Methylprednisolone or prednisolone Methylprednisolone 14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 65 💬
151 Metoprolol tartrate oral tablet Metoprolol 3件: D00601, D02358, D05011 💬 1件: ADRB1 💬 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 226 💬
152 Microgynon® 30 (oral contraceptive) - - - - 1件: 46 💬
153 Mirdametinib (pd-0325901) oral capsule or dispersible tablet PD-0325901 - - - 1件: 34 💬
154 Modified oral glucose tolerance test (50g 4-hours) Dextrose, unspecified form - - - 1件: 299 💬
155 Mono-therapy with sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
156 Multi-modal pain management [fentanyl] Fentanyl 2件: D00320, D01399 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 70 💬
157 Mycophenolate mofetil orally 1000 mg twice a day (bid) Mycophenolate mofetil 4件: D00752, D05094, D05095, D05096 💬 2件: IMPDH1, IMPDH2 💬 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 1件: 222 💬
158 Naproxen oral suspension Naproxen 1件: D00118 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 46 💬
159 Neoral oral solution - - - - 1件: 269 💬
160 Nilotinib 150mg oral capsule [tasigna] Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
161 Nilotinib 300mg oral capsule [tasigna] Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
162 Nitazoxanide 500mg oral tablet Nitazoxanide 1件: D02486 💬 - - 1件: 97 💬
163 Noxafil - 40 mg/ml sospensione orale uso orale flacone (vetro) 105 ml 1 flacone - - - - 1件: 299 💬
164 Noxafil - oral suspension 40 mg/ml - - - - 1件: 299 💬
165 Noxafil 40 mg/ml oral solution - - - - 1件: 65 💬
166 Oc oral solution treatment a - - - - 1件:  6  💬
167 Oc oral solution treatment b - - - - 1件:  6  💬
168 Oc oral solution treatment c - - - - 1件:  6  💬
169 Oc oral solution treatment d - - - - 1件:  6  💬
170 Oleovit d3 14.400 iu/ml oral drops, solution - - - - 1件: 13 💬
171 Omadacycline oral tablet [nuzyra] Omadacycline 1件: D09647 💬 - - 1件: 299 💬
172 Oral - - - - 2件: 46, 271 💬
173 Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone Mesalazine 7件: D00377, D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
174 Oral all-trans retinoic acid (atra) Tretinoin 1件: D00094 💬 3件: PML, RARA, RARB 💬 12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 1件: 94 💬
175 Oral anticoagulant treatment - - - - 1件: 86 💬
176 Oral aztreonam Aztreonam 2件: D00240, D06558 💬 - - 1件: 299 💬
177 Oral bovine type i collagen Bovine type I collagen - - - 1件: 51 💬
178 Oral bovine type ii collagen - - - - 1件: 46 💬
179 Oral budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
180 Oral budesonide suspension (mb-9) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
181 Oral budesonide suspension (obs) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
182 Oral ciprofloxacin Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
183 Oral ciprofloxacin plus inhaled colistin Ciprofloxacin 4件: D00186, D02138, D02216, D07746 💬 - - 1件: 299 💬
184 Oral corticosteroids - - - - 3件: 13, 46, 97 💬
185 Oral corticosteroids (ocs) - - - - 1件: 162 💬
186 Oral cromolyn sodium Cromoglicic acid 2件: D00526, D07753 💬 - - 1件: 98 💬
187 Oral cyclosporine Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 222 💬
188 Oral drops solution - - - - 1件: 28 💬
189 Oral era - - - - 1件: 86 💬
190 Oral erythromycin Erythromycin 9件: D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054 💬 - - 1件: 36 💬
191 Oral escitalopram Escitalopram 3件: D02567, D07704, D07913 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
192 Oral glucose tolerance test (75g 2-hour) Dextrose, unspecified form - - - 1件: 299 💬
193 Oral glutathione Glutathione 2件: D00014, D00031 💬 - - 1件: 299 💬
194 Oral ifetroban Ifetroban 1件: D04500 💬 1件: TBXA2R 💬 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 2件: 51, 86 💬
195 Oral iron Iron - - - 1件: 254 💬
196 Oral levodopa and carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
197 Oral levodopa/carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
198 Oral levosimendan Levosimendan 1件: D04720 💬 2件: PDE3A, PDE3B 💬 11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  2  💬
199 Oral lipoic acid (la) Lipoic acid 2件: D00048, D00086 💬 - - 1件: 13 💬
200 Oral methotrexate Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
201 Oral methylprednisolone 625 mg/24h x3 days Methylprednisolone 6件: D00407, D00751, D00979, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
202 Oral migalastat hcl Migalastat 1件: D10359 💬 - - 1件: 19 💬
203 Oral nutritional supplementation - - - - 1件:  2  💬
204 Oral okt3 - - - - 1件: 97 💬
205 Oral pde5 inhibitors - - - - 1件: 86 💬
206 Oral pednisolone - - - - 1件: 145 💬
207 Oral prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 49, 145 💬
208 Oral prednisone Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 251 💬
209 Oral prednisone 5mg Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 49 💬
210 Oral probiotic - - - - 1件: 291 💬
211 Oral reduced l-glutathione Glutathione 2件: D00014, D00031 💬 - - 1件: 299 💬
212 Oral roflumilast Roflumilast 1件: D05744 💬 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 1件: 299 💬
213 Oral scio-469 capsule - - - - 1件: 46 💬
214 Oral selexipag (uptravi) Selexipag 1件: D09994 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
215 Oral sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
216 Oral thc - - - - 1件: 13 💬
217 Oral treprostinil Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 2件: 51, 86 💬
218 Oral treprostinil (ut-15c) sustained release tablets Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
219 Oral vancomycin Vancomycin 2件: D00212, D00926 💬 - - 2件: 94, 296 💬
220 Oral viscous budesonide Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
221 Oral viscous budesonide (ovb) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
222 Orally disintegrating selegiline (zelapar) Selegiline 2件: D00785, D03731 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
223 Orfadin oral suspension 4mg/ml - - - - 1件: 241 💬
224 Oseltamivir Oseltamivir 2件: D00900, D08306 💬 - - 2件: 97, 299 💬
225 Other: functional oral intake scale - - - - 1件:  2  💬
226 Other: ibuprofen and isosorbide dinitrate combination Ibuprofen 6件: D00126, D00347, D00516, D01122, D04490, D06606 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 113 💬
227 Other: metformin Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 46 💬
228 Other: modified oral glucose tolerance test Dextrose, unspecified form - - - 1件: 65 💬
229 Other: oral glucose tolerance test Dextrose, unspecified form - - - 3件: 160, 195, 299 💬
230 Other: oral glucose tolerance test (ogtt) assessment arm Dextrose, unspecified form - - - 1件: 299 💬
231 Other: oral nitric oxide testing Nitric Oxide 1件: D00074 💬 - - 1件: 98 💬
232 Other: standard immune suppression, oral - - - - 1件: 228 💬
233 Other: standard of care sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 2件: 90, 301 💬
234 Overencapsulated prednisolone tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
235 Paracetamol 120mg/5ml oral suspension Acetaminophen 1件: D00217 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件:  3  💬
236 Paroxetine & prednisolone Paroxetine 12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬 2件: NR3C1, SLC6A4 💬 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 46 💬
237 Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp Paroxetine 12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬 2件: NR3C1, SLC6A4 💬 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 46 💬
238 Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp Paroxetine 12件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬 2件: NR3C1, SLC6A4 💬 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 46 💬
239 Peg-liposomal prednisolone sodium phosphate Phosphate ion 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 13, 97 💬
240 Phenylbutyrate oral tablet Phenylbutyric acid 1件: D05868 💬 - - 1件: 15 💬
241 Pioglitazone or metformin Metformin 4件: D00944, D00945, D04966, D08378 💬 3件: PPARG, PRKAA1, PRKAA2 💬 25件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 1件: 265 💬
242 Pitolisant oral tablets Pitolisant 1件: D10749 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 1件: 193 💬
243 Pomalidomide oral product Pomalidomide 1件: D08976 💬 2件: IL6, TNF 💬 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 227 💬
244 Powder for oral suspension) - - - - 1件: 113 💬
245 Predinose oral - - - - 1件: 70 💬
246 Prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
247 Prednisolone & dipyridamole Dipyridamole 9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 3件: NR3C1, PDE4A, PDE5A 💬 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
248 Prednisolone + mabthera Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 61 💬
249 Prednisolone 1mg tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
250 Prednisolone 2,5 mg tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
251 Prednisolone 20 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
252 Prednisolone 40 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
253 Prednisolone 5 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 46, 51 💬
254 Prednisolone 5 mg jenapharm Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 41 💬
255 Prednisolone 5 mg tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
256 Prednisolone 5mg gastro-resistant tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 51 💬
257 Prednisolone 5mg tablet Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
258 Prednisolone acetate Acetate 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 222 💬
259 Prednisolone and chlorambucil Chlorambucil 9件: D00266, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 222 💬
260 Prednisolone and mycophenolate mofetil Mycophenolate mofetil 12件: D00472, D00752, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05094, D05095, D05096 💬 3件: IMPDH1, IMPDH2, NR3C1 💬 4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 1件: 222 💬
261 Prednisolone and taper Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 51 💬
262 Prednisolone labesfal Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
263 Prednisolone sodium metasulphobenzoate Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
264 Prednisolone sodium phosphate Phosphate ion 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 13, 97 💬
265 Prednisolone sodium succinate Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 95 💬
266 Prednisolone tablets b.p. 5mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
267 Prednisolone tablets bp Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
268 Prednisolone tablets bp 1 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
269 Prednisolone tablets usp 5 mg Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
270 Prednisolone-dipyridamole Dipyridamole 9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 3件: NR3C1, PDE4A, PDE5A 💬 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
271 Prednisolone/prednisone Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 49 💬
272 Prednisone 0,5 mg/kg orally on alternate days Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 222 💬
273 Prednisone or prednisolone Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
274 Prednisone/prednisolone Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 35 💬
275 Prn1008 oral tablet - - - - 1件: 35 💬
276 Procedure: celiac block with triamcinolone and bupivicaine Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 298 💬
277 Procedure: oral glucose tolerance test Dextrose, unspecified form - - - 1件: 299 💬
278 Pyridoxine plus prednisolone Prednisolone 10件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02179, D03301, D08454 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 145 💬
279 Rapamune - 1 mg 100 compresse rivestite in blister uso orale - - - - 1件:  2  💬
280 Rapamune 1 mg/ml solución oral - - - - 1件: 158 💬
281 Raxone - 150 mg- compresse rivestite con film- uso orale- flacone (hdpe)- 180 compresse - - - - 1件: 113 💬
282 Rebif new formulation + ibuprofen prn Ibuprofen 4件: D00126, D01122, D04490, D06606 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 13 💬
283 Rebif new formulation + prophylactic ibuprofen Ibuprofen 4件: D00126, D01122, D04490, D06606 💬 2件: PTGS1, PTGS2 💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 13 💬
284 Revatio 10 mg/ml powder for oral suspension - - - - 1件: 86 💬
285 Revatio oral - - - - 1件: 86 💬
286 Rifaximin oral tablet Rifaximin 1件: D02554 💬 - - 1件: 99 💬
287 Rigosertib oral capsules / rigosertib intravenous Rigosertib 1件: D10154 💬 1件: PLK1 💬 4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 1件: 36 💬
288 Riluzole oral soluble film Riluzole 1件: D00775 💬 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 1件:  2  💬
289 Riluzole oral soluble film (rosf) 50 mg Riluzole 1件: D00775 💬 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 1件:  2  💬
290 Riociguat granules 0.3% for oral application Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 86 💬
291 Riociguat oral product Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 86 💬
292 Riociguat oral tablet Riociguat 1件: D09572 💬 3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 88 💬
293 Risedronate oral tablet Risedronic acid 3件: D00942, D03234, D08484 💬 1件: FDPS 💬 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 274 💬
294 Roflumilast oral tablet Roflumilast 1件: D05744 💬 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 1件: 299 💬
295 Ropinirole oral product Ropinirole 2件: D00784, D08489 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
296 Rufinamide oral suspension Rufinamide 1件: D05775 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 144 💬
297 Sabril granules for oral use - - - - 1件: 145 💬
298 Saccharomyces boulardii oral tablet - - - - 1件: 51 💬
299 Sb-681323 oral tablets - - - - 1件: 46 💬
300 Semi continuous intra-oral administration of ld/cd - - - - 1件:  6  💬
301 Sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
302 Sildenafil (50 mg) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 85 💬
303 Sildenafil (acute-1 hour) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 299 💬
304 Sildenafil (as citrate) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
305 Sildenafil (revatio) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
306 Sildenafil (revatio) 20 mg tid Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
307 Sildenafil (subchronic-4 weeks) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 299 💬
308 Sildenafil 20 mg tablets Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 278 💬
309 Sildenafil 20mg Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 2件: 51, 86 💬
310 Sildenafil 20mg and bosentan 62.5mg Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 51, 86 💬
311 Sildenafil 40mg oral capsule Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 299 💬
312 Sildenafil and losartan Losartan 4件: D00357, D02229, D08146, D08514 💬 2件: AGTR1, PDE5A 💬 18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 85 💬
313 Sildenafil by injection Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 210 💬
314 Sildenafil citrate Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 4件: 51, 85, 86, 225 💬
315 Sildenafil citrate (uk-92,480) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
316 Sildenafil filmtabletten Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
317 Sildenafil singly or in association with bosentan Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
318 Sildenafil therapy Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 51 💬
319 Simvastatin 20mg/5ml oral suspension Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 34 💬
320 Sirolimus oral liquid product 1mg/ml Sirolimus 1件: D00753 💬 1件: MTOR 💬 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 1件: 278 💬
321 Sirolimus oral product Sirolimus 1件: D00753 💬 1件: MTOR 💬 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 2件: 89, 158 💬
322 Sitagliptin and metformin Metformin 3件: D00944, D04966, D08516 💬 3件: DPP4, PRKAA1, PRKAA2 💬 20件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, mTOR signaling pathway 1件: 233 💬
323 Sitaxsentan and sildenafil Sildenafil 3件: D02229, D07171, D08514 💬 2件: EDNRA, PDE5A 💬 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
324 Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth Dextrose, unspecified form 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
325 Soluble prednisolone tablets Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 145 💬
326 Sporanox 10 mg/ml oral solution - - - - 1件: 299 💬
327 Standard analgesia use [fentanyl] Fentanyl 2件: D00320, D01399 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 70 💬
328 Sulphasalazine + hydroxychloroquine or prednisolone Hydroxychloroquine 9件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D08050 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
329 Sustained-release oral dalfampridine Dalfampridine 1件: D04127 💬 4件: KCNA4, KCNC3, KCND2, KCND3 💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 1件: 13 💬
330 Tadalafil and sildenafil Sildenafil 3件: D02008, D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 113 💬
331 Tadalafil oral suspension Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
332 Tadalafil- tablet or oral suspension Tadalafil 1件: D02008 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
333 Teicoplanin sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution. Teicoplanin 1件: D02142 💬 - - 1件: 299 💬
334 Teriflunomide 14 mg oral tablet [aubagio] Teriflunomide 1件: D10172 💬 1件: DHODH 💬 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 1件: 13 💬
335 Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule Thalidomide 1件: D00754 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 96 💬
336 Tizanidine (sublingual or oral) Tizanidine 2件: D00776, D08611 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件: 13 💬
337 Tofacitinib 5mg oral tablet [xeljanz] 16 week trial Tofacitinib 1件: D09970 💬 4件: JAK1, JAK2, JAK3, TYK2 💬 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 1件: 84 💬
338 Tolvaptan oral tablet Tolvaptan 1件: D01213 💬 1件: AVPR2 💬 3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 1件: 72 💬
339 Transdermal fentanyl matrix, gabapentin Fentanyl 3件: D00320, D00332, D01399 💬 6件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬 12件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle 1件: 70 💬
340 Translarna 1000 mg granules for oral suspension - - - - 1件: 113 💬
341 Translarna 125 mg granules for oral suspension - - - - 1件: 113 💬
342 Translarna 250 mg granules for oral suspension - - - - 1件: 113 💬
343 Trazodone hydrochloride oral solution Trazodone 2件: D00820, D08626 💬 4件: HTR2A, HTR2B, HTR2C, SLC6A4 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件:  2  💬
344 Trexan+salazopyrin+oxiklorin+prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
345 Trexan+salazopyrin+oxiklorin+prednisolone + infliximab Infliximab 9件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02598, D03301 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
346 Triamcinolone Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
347 Triamcinolone 40 milligrams (kenacort, bristol myers squip) Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
348 Triamcinolone acetonide Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 35, 46, 56 💬
349 Triamcinolone acetonide and normal saline solution Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 70 💬
350 Triamcinolone hexacetonid (lederspan) Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
351 Triamcinolone hexacetonide Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
352 Triamcinolone hexacetonide (lederspan) Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
353 Vamorolone 4% suspension for oral dosing Vamorolone 1件: D11000 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
354 Ventoline oral solution 0,4mg/ml - - - - 1件: 111 💬
355 Vfend 40 mg/ml powder for oral suspension - - - - 1件: 299 💬
356 Vigabatrin Vigabatrin 1件: D00535 💬 1件: ABAT 💬 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 2件: 145, 158 💬
357 Vigabatrin (sabril) Vigabatrin 1件: D00535 💬 1件: ABAT 💬 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件: 158 💬
358 Vigabatrin tablets Vigabatrin 1件: D00535 💬 1件: ABAT 💬 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件: 145 💬
359 Vigabatrin: vigabatrin new st formulation then sabril® Vigabatrin 1件: D00535 💬 1件: ABAT 💬 7件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件: 145 💬
360 Z102 (prednisolone and dipyridamole). Dipyridamole 9件: D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 3件: NR3C1, PDE4A, PDE5A 💬 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬

先頭へ